0001415889-22-008799.txt : 20220817
0001415889-22-008799.hdr.sgml : 20220817
20220817181543
ACCESSION NUMBER: 0001415889-22-008799
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220815
FILED AS OF DATE: 20220817
DATE AS OF CHANGE: 20220817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Geist William
CENTRAL INDEX KEY: 0001832210
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 221175699
MAIL ADDRESS:
STREET 1: 900 MIDDLESEX TURNPIKE
STREET 2: C/O QUANTERIX CORPORATION
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
form4-08172022_030831.xml
X0306
4
2022-08-15
0000842023
BIO-TECHNE Corp
TECH
0001832210
Geist William
614 MCKINLEY PL N E
MINNEAPOLIS
MN
55413
false
true
false
false
PRESIDENT, PROTEIN SCIENCES
Common Stock
2490
D
Restricted Stock Units
2022-08-15
4
A
0
1785
0
A
Common Stock
1785
1785
D
Stock Options (Right to Buy)
378.08
2022-08-15
4
A
0
5550
0
A
2029-08-15
Common Stock
5550
5550
D
Stock Options (Right to Buy)
378.08
2022-08-15
4
A
0
7400
0
A
2029-08-15
Common Stock
7400
7400
D
Restricted Stock Units
Common Stock
840
840
D
Stock Options (Right to Buy)
401.57
2029-02-01
Common Stock
2984
2984
D
Stock Options (Right to Buy)
401.57
2029-02-01
Common Stock
3978
3978
D
Represents 2,490 shares of restricted stock for which the risk of forfeiture will lapse as to 830 shares on each of February 1, 2023, February 1, 2024 and February 1, 2025.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 1,850 shares vest on each of 8/15/2023, 8/15/2024, 8/51/2025 and 8/15/2026.
Options to purchase 995 shares vest on each of 2/1/2023 and 2/1/2024 and options to purchase 994 shares vest on each of 2/1/2025 and 2/1/2026.
/s/ Brenda S. Furlow as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed
2022-08-17